Table. Baseline Clinical, Biological, and Histologic Characteristics of 36 Patients With CUA.
| Characteristic | No. (%) |
|---|---|
| Demographic characteristics | |
| Female to male ratio | 2.6 |
| Age at diagnosis, median (range), y | 64 (33-89) |
| Comorbidities | |
| Dialysis | 30 (83) |
| Dialysis-to-CUA interval, median (range), mo | 24 (1-156) |
| Diabetes | 23 (64) |
| Hypertension | 33 (92) |
| BMI >30 kg/m2 | 14 (39) |
| Vitamin K antagonists | 16 (44) |
| Clinical characteristics | |
| Proximal CUA | 10 (28) |
| Necrosis | 26 (72) |
| Ulceration | 24 (67) |
| Livedo reticularis | 18 (50) |
| Indurated plaques | 15 (42) |
| Nodular lesions | 9 (25) |
| Biological characteristics | |
| Serum calcium, median (range), mmol/L | 2.26 (1.89-2.84) |
| Serum phosphate, median (range), mmol/L | 1.57 (0.93-3.68) |
| Calcium × phosphate product >4.5 mmol2/L2 | 12 (33) |
| Serum parathyroid hormone >90 ng/L | 24 (67) |
| Serum albumin, median (range), g/L | 28 (18-37) |
| Cutaneous histologic features | 29 |
| Vascular calcifications | 29 (100) |
| Interstitial calcifications | 22 (76) |
| Thrombosis | 5 (14) |
Abbreviations: BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); CUA, calcific uremic arteriolopathy.
Conversion factors: To convert mmol/L to mg/dL, divide by 0.25; to convert ng/L to pg/mL, divide by 1.0; to convert g/L to g/dL, divide by 10.